Dental Bone Grafts & Substitutes Market by Type, Product, Application, End-User

Description

List of Tables

[182 Pages Report] The Dental Bone Grafts & Substitutes Market size was estimated at USD 1.14 billion in 2023 and expected to reach USD 1.22 billion in 2024, at a CAGR 7.29% to reach USD 1.87 billion by 2030.

The dental bone grafts & substitutes include products and materials operated in dental surgery to stimulate bone growth and facilitate bone regeneration in areas with bone loss or deficiency. The source for the material of these products can be human bone, animal bone and synthetic material. Rising incidences of periodontal diseases, tooth loss, and oral ailments drive the need for bone graft procedures for the aged and adult population across the globe. Increased awareness about oral hygiene and aesthetic concerns also spur market growth. However, high cost associated with the grafts and substitutes can be prohibitive for patients. Additionally, limited coverage of dental procedures in the insurance sector restricts the spread of the market. Innovations in tissue engineering and regenerative medicine are helping in enhancing graft material options and procedures. In addition, rising incorporation of 3D printing and AI is creating new opportunity for the development of grafts and substitutes in the upcoming years.

KEY MARKET STATISTICS
Base Year [2023]	USD 1.14 billion
Estimated Year [2024]	USD 1.22 billion
Forecast Year [2030]	USD 1.87 billion
CAGR (%)	7.29%

Regional Insights

The Americas have a sufficient market for dental bone grafts and substitutes due to the prevalence of the increased aged population, awareness about health, and preference for minimally invasive surgeries. Investments primarily focused on biomaterial research and the development of synthetic alternatives to reduce dependency on human and animal-derived products expanded the market in the region. In European countries, well-established healthcare systems and high medical device standards support the market's growth. Similarly, the stringent regulatory environment of the European Union ensures that products are safe and effective, influencing consumer confidence in newer technologies. The Middle East is experiencing growth in the dental bone grafts market due to increasing medical tourism and improving healthcare infrastructure. African regions have slow emerging healthcare sectors with new investments in technological advancements, which can be a potential element for the growth of the market. In the APAC region, increased population growth, growing governmental support for healthcare, and an aged population's preferences for minimally invasive surgeries paved the way for the spread of the market in countries such as Japan, China, and India.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Dental Bone Grafts & Substitutes Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Increased need for dental restorative procedures
- Increased awareness about oral hygiene and aesthetic concerns

Market Restraints
- Expense associated with dental grafts and surgeries

Market Opportunities
- Innovations in tissue engineering and regenerative medicine
- Investments in scalable production technologies

Market Challenges
- Corners over limited reimbursement policies for dental procedures

Market Segmentation Analysis
- Type: Rising use of Allograft in dental implants due to ability to heal naturally.
- End User: emerging role of the dental bone grafts in dental clinic

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Dental Bone Grafts & Substitutes Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Dental Bone Grafts & Substitutes Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

ZimVie Inc. Expanded Dental Implant Solutions in Japan with Launch of TSX Implant

ZimVie Inc., a life sciences company in dental and spine solutions, announced the release of the TSX Implant in Japan. The TSX Implant, known for its suitability for immediate use post-extraction and effectiveness in both soft and dense bone. The implant has features such as peri-implant health, consistent bone maintenance at the crestal level, durable osseointegration, and prosthetic stability. [Published On: 2024-02-07]

Innovations in Bone Healing as Renovos Biologics Limited BMP-2 Gained FDA Recognition

Renovos Biologics Limited has received FDA approval for Renovite BMP-2, a cutting-edge synthetic nanoclay gel infused with bone morphogenic protein 2 (BMP-2). Renovite BMP-2 serves as an alternative to traditional bone grafts, facilitating precise and targeted bone regeneration while preventing BMP-2 leakage. The gel is formulated to degrade naturally as new bone tissue forms, enhancing safety and efficacy. [Published On: 2024-01-04]

Strategic Expansion in Bone Regeneration Technologies as Biocomposites Ltd. Acquired Artoss, Inc.

Artoss, Inc., a company in advanced bone graft substitutes employing its unique NanoBone technology acquired by Biocomposites Ltd. company officials highlighted this acquisition as pivotal, enhancing their portfolio with innovative, ready-to-use products and strengthening their position in bone regeneration and infection management solutions in orthopedic care. [Published On: 2023-06-14]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Dental Bone Grafts & Substitutes Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Dental Bone Grafts & Substitutes Market, highlighting leading vendors and their innovative profiles. These include AlloSource, Baxter International Inc., BioHorizons, Inc, botiss biomaterials GmbH, Collagen Matrix, Inc., Dentium Co., Ltd, Dentsply Sirona, Geistlich Pharma AG, Hannox International Corp., immer Biomet Holdings, Inc., Institut Straumann AG, Integra LifeSciences Corporation, Johnson & Johnson, LIFENET HEALTH, INC., Maxigen Biotech Inc., Medtronic PLC, NovaBone Products, LLC by Halma plc, Orthofix Medical Inc., Osteogenics Biomedical, Inc., RTI Surgical, Inc., Stryker, and ZimVie Inc..

Market Segmentation & Coverage

This research report categorizes the Dental Bone Grafts & Substitutes Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Allograft
- Alloplast
- Synthetic Bone Graft
- Xenograft

Product
- Bio-OSS
- Grafton
- OsteoGraf

Application
- Implant Bone Regeneration
- Periodontal Defect Regeneration
- Ridge Augmentation
- Sinus Lift
- Socket Preservation

End-User
- Dental Clinics
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-A339DAEFB1BD

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increased need for dental restorative procedures
  - 5.1.1.2. Increased awareness about oral hygiene and aesthetic concerns
- 5.1.2. Restraints
  - 5.1.2.1. Expense associated with dental grafts and surgeries
- 5.1.3. Opportunities
  - 5.1.3.1. Innovations in tissue engineering and regenerative medicine
  - 5.1.3.2. Investments in scalable production technologies
- 5.1.4. Challenges
  - 5.1.4.1. Corners over limited reimbursement policies for dental procedures
5.2. Market Segmentation Analysis
- 5.2.1. Type: Rising use of Allograft in dental implants due to ability to heal naturally.
- 5.2.2. End User: emerging role of the dental bone grafts in dental clinic
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Dental Bone Grafts & Substitutes Market, by Type

6.1. Introduction
6.2. Allograft
6.3. Alloplast
6.4. Synthetic Bone Graft
6.5. Xenograft

7. Dental Bone Grafts & Substitutes Market, by Product

7.1. Introduction
7.2. Bio-OSS
7.3. Grafton
7.4. OsteoGraf

8. Dental Bone Grafts & Substitutes Market, by Application

8.1. Introduction
8.2. Implant Bone Regeneration
8.3. Periodontal Defect Regeneration
8.4. Ridge Augmentation
8.5. Sinus Lift
8.6. Socket Preservation

9. Dental Bone Grafts & Substitutes Market, by End-User

9.1. Introduction
9.2. Dental Clinics
9.3. Hospitals

10. Americas Dental Bone Grafts & Substitutes Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Dental Bone Grafts & Substitutes Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Dental Bone Grafts & Substitutes Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. ZimVie Inc. Expanded Dental Implant Solutions in Japan with Launch of TSX Implant
- 13.3.2. Innovations in Bone Healing as Renovos Biologics Limited BMP-2 Gained FDA Recognition
- 13.3.3. Strategic Expansion in Bone Regeneration Technologies as Biocomposites Ltd. Acquired Artoss, Inc.
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio